Depression and Anxiety Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are generally healthy
- People with a Body Mass Index (a measure of body weight relative to height) between 18.5 and 29.9, which is considered a normal to healthy range
- People who weigh at least 110 pounds
Who may not be able to join:
- People who are pregnant
- People who are currently breastfeeding
- People who smoke
- People who have diabetes
- People who drink heavily
- People whose memory or thinking feels off to them personally, even without a formal diagnosis (as measured by a standard memory and thinking test with a score below 26)
- People who are unable to understand or complete thinking and memory-based tasks
- People who take medications that could affect the results of the study, such as stimulant medications
- People who use cannabis products
- People who have been formally diagnosed with a mental illness
- People who have heart or nervous system conditions
- People with high blood pressure that is not being controlled
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Liwei Gu, PhD, University of Florida
Phone: 479-203-8170
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline cognitive performance score after intervention/placebo; Change from baseline cognitive performance score after intervention/placebo - continued; Change from baseline cognitive performance score after intervention/placebo - continued; Change from baseline monoamine oxidase (MAOs) activity; Change from baseline neurotransmitters; Change from baseline brain-derived neurotrophic factors; Change from baseline cortisol, TNF-α, high sensitivity C-reactive protein, and LPS binding protein
Can't join this trial?
Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.